sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

Category : Pharmaceuticals and Healthcare QY Research Pages :99
Published Date : 2020-09-16

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the B-Cell Maturation AntigenBCMA Targeted Therapies Market with our analysts monitoring the situation across the globe.
This report focuses on the global B-Cell Maturation Antigen(BCMA) Targeted Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the B-Cell Maturation Antigen(BCMA) Targeted Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Transposagen Biopharmaceuticals Sutro Biopharma Malin Corporation Eureka Therapeutics firstVentury Equity Five Prime Therapeutics Credit Suisse Securities Dana-Farber Cancer Institute Deerfield Partners Onyx Pharmaceuticals Juno Therapeutics Market segment by Type, the product can be split into Bispecific Antibodies Antibody Drug Conjugates Chimeric Antigen Receptor T-Cells Market segment by Application, split into Liver Cancer Respiratory Cancer Brain Cancer Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global B-Cell Maturation Antigen(BCMA) Targeted Therapies status, future forecast, growth opportunity, key market and key players. To present the B-Cell Maturation Antigen(BCMA) Targeted Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of B-Cell Maturation Antigen(BCMA) Targeted Therapies are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue 1.4 Market Analysis by Type 1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Bispecific Antibodies 1.4.3 Antibody Drug Conjugates 1.4.4 Chimeric Antigen Receptor T-Cells 1.5 Market by Application 1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2026 1.5.2 Liver Cancer 1.5.3 Respiratory Cancer 1.5.4 Brain Cancer 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Impact 1.6.1 How the Covid-19 is Affecting the B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry 1.6.1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and B-Cell Maturation Antigen(BCMA) Targeted Therapies Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Perspective (2015-2026) 2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Trends by Regions 2.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Share by Regions (2015-2020) 2.2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth Strategy 2.3.6 Primary Interviews with Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Market Size 3.1.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Revenue (2015-2020) 3.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Players (2015-2020) 3.1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio 3.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2019 3.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players Head office and Area Served 3.4 Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service 3.5 Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Type (2015-2020) 4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2021-2026) 5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Application (2015-2026) 5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2019-2020) 6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 7 Europe 7.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Europe (2019-2020) 7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 7.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 8 China 8.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 8.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in China (2019-2020) 8.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 8.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 9 Japan 9.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Japan (2019-2020) 9.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 9.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 10.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 11 India 11.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 11.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in India (2019-2020) 11.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 11.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020) 12.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Central & South America (2019-2020) 12.3 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) 12.4 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Transposagen Biopharmaceuticals 13.1.1 Transposagen Biopharmaceuticals Company Details 13.1.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue 13.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.1.4 Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)) 13.1.5 Transposagen Biopharmaceuticals Recent Development 13.2 Sutro Biopharma 13.2.1 Sutro Biopharma Company Details 13.2.2 Sutro Biopharma Business Overview and Its Total Revenue 13.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.2.4 Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.2.5 Sutro Biopharma Recent Development 13.3 Malin Corporation 13.3.1 Malin Corporation Company Details 13.3.2 Malin Corporation Business Overview and Its Total Revenue 13.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.3.4 Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.3.5 Malin Corporation Recent Development 13.4 Eureka Therapeutics 13.4.1 Eureka Therapeutics Company Details 13.4.2 Eureka Therapeutics Business Overview and Its Total Revenue 13.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.4.4 Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.4.5 Eureka Therapeutics Recent Development 13.5 firstVentury Equity 13.5.1 firstVentury Equity Company Details 13.5.2 firstVentury Equity Business Overview and Its Total Revenue 13.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.5.4 firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.5.5 firstVentury Equity Recent Development 13.6 Five Prime Therapeutics 13.6.1 Five Prime Therapeutics Company Details 13.6.2 Five Prime Therapeutics Business Overview and Its Total Revenue 13.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.6.4 Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.6.5 Five Prime Therapeutics Recent Development 13.7 Credit Suisse Securities 13.7.1 Credit Suisse Securities Company Details 13.7.2 Credit Suisse Securities Business Overview and Its Total Revenue 13.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.7.4 Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.7.5 Credit Suisse Securities Recent Development 13.8 Dana-Farber Cancer Institute 13.8.1 Dana-Farber Cancer Institute Company Details 13.8.2 Dana-Farber Cancer Institute Business Overview and Its Total Revenue 13.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.8.4 Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.8.5 Dana-Farber Cancer Institute Recent Development 13.9 Deerfield Partners 13.9.1 Deerfield Partners Company Details 13.9.2 Deerfield Partners Business Overview and Its Total Revenue 13.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.9.4 Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.9.5 Deerfield Partners Recent Development 13.10 Onyx Pharmaceuticals 13.10.1 Onyx Pharmaceuticals Company Details 13.10.2 Onyx Pharmaceuticals Business Overview and Its Total Revenue 13.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 13.10.4 Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 13.10.5 Onyx Pharmaceuticals Recent Development 13.11 Juno Therapeutics 10.11.1 Juno Therapeutics Company Details 10.11.2 Juno Therapeutics Business Overview and Its Total Revenue 10.11.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction 10.11.4 Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) 10.11.5 Juno Therapeutics Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Market Segments Table 2. Key Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Table 3. Ranking of Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Bispecific Antibodies Table 6. Key Players of Antibody Drug Conjugates Table 7. Key Players of Chimeric Antigen Receptor T-Cells Table 8. COVID-19 Impact Global Market: (Four B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Forecast Scenarios) Table 9. Opportunities and Trends for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players to Combat Covid-19 Impact Table 13. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions (2015-2020) (US$ Million) Table 16. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2015-2020) Table 17. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth Strategy Table 23. Main Points Interviewed from Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Players Table 24. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Players (2015-2020) (Million US$) Table 25. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Players (2015-2020) Table 26. Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies as of 2019) Table 27. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service Table 30. Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 33. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Type (2015-2020) Table 34. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2021-2026) Table 35. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Application (2015-2020) Table 36. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 37. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Application (2021-2026) Table 38. North America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 39. North America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 40. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 41. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 42. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 43. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 44. Europe Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 45. Europe Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 46. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 47. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 48. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 49. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 50. China Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 51. China Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 52. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 53. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 54. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 55. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 56. Japan Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 57. Japan Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 58. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 59. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 60. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 61. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 64. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 66. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 68. India Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 69. India Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 70. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 71. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 72. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 73. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 74. Central & South America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020) Table 76. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020) Table 78. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020) Table 80. Transposagen Biopharmaceuticals Company Details Table 81. Transposagen Biopharmaceuticals Business Overview Table 82. Transposagen Biopharmaceuticals Product Table 83. Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 84. Transposagen Biopharmaceuticals Recent Development Table 85. Sutro Biopharma Company Details Table 86. Sutro Biopharma Business Overview Table 87. Sutro Biopharma Product Table 88. Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 89. Sutro Biopharma Recent Development Table 90. Malin Corporation Company Details Table 91. Malin Corporation Business Overview Table 92. Malin Corporation Product Table 93. Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 94. Malin Corporation Recent Development Table 95. Eureka Therapeutics Company Details Table 96. Eureka Therapeutics Business Overview Table 97. Eureka Therapeutics Product Table 98. Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 99. Eureka Therapeutics Recent Development Table 100. firstVentury Equity Company Details Table 101. firstVentury Equity Business Overview Table 102. firstVentury Equity Product Table 103. firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 104. firstVentury Equity Recent Development Table 105. Five Prime Therapeutics Company Details Table 106. Five Prime Therapeutics Business Overview Table 107. Five Prime Therapeutics Product Table 108. Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 109. Five Prime Therapeutics Recent Development Table 110. Credit Suisse Securities Company Details Table 111. Credit Suisse Securities Business Overview Table 112. Credit Suisse Securities Product Table 113. Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 114. Credit Suisse Securities Recent Development Table 115. Dana-Farber Cancer Institute Business Overview Table 116. Dana-Farber Cancer Institute Product Table 117. Dana-Farber Cancer Institute Company Details Table 118. Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 119. Dana-Farber Cancer Institute Recent Development Table 120. Deerfield Partners Company Details Table 121. Deerfield Partners Business Overview Table 122. Deerfield Partners Product Table 123. Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 124. Deerfield Partners Recent Development Table 125. Onyx Pharmaceuticals Company Details Table 126. Onyx Pharmaceuticals Business Overview Table 127. Onyx Pharmaceuticals Product Table 128. Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 129. Onyx Pharmaceuticals Recent Development Table 130. Juno Therapeutics Company Details Table 131. Juno Therapeutics Business Overview Table 132. Juno Therapeutics Product Table 133. Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$) Table 134. Juno Therapeutics Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type: 2020 VS 2026 Figure 2. Bispecific Antibodies Features Figure 3. Antibody Drug Conjugates Features Figure 4. Chimeric Antigen Receptor T-Cells Features Figure 5. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2026 Figure 6. Liver Cancer Case Studies Figure 7. Respiratory Cancer Case Studies Figure 8. Brain Cancer Case Studies Figure 9. Others Case Studies Figure 10. B-Cell Maturation Antigen(BCMA) Targeted Therapies Report Years Considered Figure 11. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions: 2020 VS 2026 Figure 13. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Players in 2019 Figure 16. Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies as of 2019 Figure 17. The Top 10 and 5 Players Market Share by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2019 Figure 18. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Transposagen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Transposagen Biopharmaceuticals Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 27. Sutro Biopharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Sutro Biopharma Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 29. Malin Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Malin Corporation Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 31. Eureka Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Eureka Therapeutics Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 33. firstVentury Equity Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. firstVentury Equity Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 35. Five Prime Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Five Prime Therapeutics Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 37. Credit Suisse Securities Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Credit Suisse Securities Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 39. Dana-Farber Cancer Institute Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Dana-Farber Cancer Institute Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 41. Deerfield Partners Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Deerfield Partners Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 43. Onyx Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Onyx Pharmaceuticals Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 45. Juno Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Juno Therapeutics Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Get Free Sample

Related Reports

COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)